Corrigendum to “Ezetimibe, a NPC1L1 inhibitor, attenuates neuronal apoptosis through AMPK dependent autophagy activation after MCAO in rats” [Experimental Neurology, 2018 Sep:307:12–23.] (Experimental Neurology (2018) 307 (12–23), (S0014488618301626), (10.1016/j.expneurol.2018.05.022))

0Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The authors regret the presence of certain flaws in Fig. 8 that necessitated corrections. The representative panel of Beclin1 in Fig. 8 A was incorrect. During the creation of the representative figure, an error occurred that the Beclin1 image was mistakenly sourced from another protein. This was an unintentional oversight during the assembly of the figure. The other elements of the figure remain unchanged. These changes do not affect the results or conclusions of this study. The corrected figure is presented below. The authors would like to apologise for any inconvenience caused. Revised Fig here[Formula presented]

Cite

CITATION STYLE

APA

Yu, J., Li, X., Matei, N., McBride, D., Tang, J., Yan, M., & Zhang, J. H. (2024, September 1). Corrigendum to “Ezetimibe, a NPC1L1 inhibitor, attenuates neuronal apoptosis through AMPK dependent autophagy activation after MCAO in rats” [Experimental Neurology, 2018 Sep:307:12–23.] (Experimental Neurology (2018) 307 (12–23), (S0014488618301626), (10.1016/j.expneurol.2018.05.022)). Experimental Neurology. Academic Press Inc. https://doi.org/10.1016/j.expneurol.2024.114865

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free